Compounded GLP-1 Injections
Treatment options
Tirzepatide · Semaglutide
Your provider picks the right fit based on your goals and history.
All plans include
- Provider review, no cost upfront
- 3-4 day shipping
- Message your provider anytime
- Customized patient portal
PepHaūs Guarantee
No charge until a U.S.-licensed provider approves your prescription. Every refill compounded by a U.S.-licensed pharmacy. Pause, change, or cancel anytime from your portal.
Starting at
$212/mo*$249/mo*
*Quarterly plan. New patient pricing. Not charged unless prescribed.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It quiets food noise, slows digestion, supports insulin response, and helps you feel full on less food.
Available as: Tirzepatide or Semaglutide. Your provider picks the right fit based on your goals, history, and how your body responds.
Two cadences. Both are flexible. Cancel anytime from your patient portal.
Monthly
$249/mo
Billed monthly. Cancel anytime.
Quarterly Save 15%
$212/mo
Billed every 3 months. Best value.
Complete your intake
A short medical questionnaire about your goals and history. Two minutes. No payment up front.
Provider review
A U.S.-licensed provider in your state reviews your intake. If a live video visit is required, it's scheduled at no additional cost.
Care, delivered
If approved, your prescription is filled by a U.S.-licensed compounding pharmacy and shipped free expedited to your door.
How is compounded tirzepatide different from the brand-name pen?
Same active ingredient. Filled by a U.S.-licensed 503A compounding pharmacy instead of large-scale commercial manufacturing. A provider prescribes after reviewing your intake. Compounded tirzepatide is not FDA-approved. Its safety and effectiveness have not been independently established by the FDA.
Can I switch from semaglutide?
Many patients do. Your provider reviews your current dose and any reactions. If tirzepatide is appropriate they start you at the 2.5 mg weekly stage. The titration ladder is the same for new patients and switchers.
What is the titration schedule?
Five stages over roughly six months. Weeks 1 to 4 at 2.5 mg. Weeks 5 to 8 at 5.0 mg. Weeks 9 to 12 at 7.5 mg. Week 13 and beyond at 10.0 to 15.0 mg. Your provider only advances when the current dose is tolerated.
What are the common side effects?
Most patients report nausea. Reduced appetite. Mild GI changes during the first weeks of each new dose. These usually fade. Your provider reviews any concerns in the portal and slows the titration if needed.
Does insurance cover this?
No. PepHaūs is cash-pay. The price you see covers the medication. Supplies. Provider review. Shipping. No insurance billing. No prior-authorization waiting.
Every Tirzepatide prescription requires a full provider review of your medical history. Common side effects, drug interactions, contraindications, and storage details are documented on our safety page.
Full Tirzepatide safety information